Antipsychotics: Past, Present, and Future (Part 2): Article 2 of 3.

Q2 Medicine Senior Care Pharmacist Pub Date : 2024-02-01 DOI:10.4140/TCP.n.2024.57
Steven Levenson
{"title":"Antipsychotics: Past, Present, and Future (Part 2): Article 2 of 3.","authors":"Steven Levenson","doi":"10.4140/TCP.n.2024.57","DOIUrl":null,"url":null,"abstract":"<p><p>The history of antipsychotics in nursing facilities is one piece of a much larger, more complex puzzle. In many ways, it reflects the virtues and limitations of the entire health care system and those who provide care. None of the issues related to the use of antipsychotics are specific to these medications or to nursing facilities. After decades of effort to reduce unwarranted antipsychotics use, the current situation is still a work in progress. Many widely held assumptions and standard narratives, such as those about behavior, the place of medications in person-centered care, and the causes of inappropriate medication use are only partially correct. This second of three articles is not intended to discuss how to diagnose and manage behavior disorders or choose medications. Instead, it addresses the diverse perspectives and key players that have been involved and the results of their efforts. Ultimately, this will set the stage for specific recommendations (part 3) about learning from past efforts surrounding antipsychotics to identify more definitive and lasting improvements in the future. Part 1 of this series covered the history of attempts to influence use of medications-especially, antipsychotics-in nursing facility care of residents with behavior, mood, and cognitive issues. These improvement efforts can be described as fragmented, often ineffectual, and politically fraught. After decades of effort, and despite a significant reduction in the indiscriminate use of antipsychotics, psychotropics are still widely used in nursing facilities.<sup>1</sup> The extent of improvement overall in managing individuals with dementia and other diverse behavior, mood, and cognitive issues is unclear.</p>","PeriodicalId":41635,"journal":{"name":"Senior Care Pharmacist","volume":"39 2","pages":"57-72"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Senior Care Pharmacist","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4140/TCP.n.2024.57","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The history of antipsychotics in nursing facilities is one piece of a much larger, more complex puzzle. In many ways, it reflects the virtues and limitations of the entire health care system and those who provide care. None of the issues related to the use of antipsychotics are specific to these medications or to nursing facilities. After decades of effort to reduce unwarranted antipsychotics use, the current situation is still a work in progress. Many widely held assumptions and standard narratives, such as those about behavior, the place of medications in person-centered care, and the causes of inappropriate medication use are only partially correct. This second of three articles is not intended to discuss how to diagnose and manage behavior disorders or choose medications. Instead, it addresses the diverse perspectives and key players that have been involved and the results of their efforts. Ultimately, this will set the stage for specific recommendations (part 3) about learning from past efforts surrounding antipsychotics to identify more definitive and lasting improvements in the future. Part 1 of this series covered the history of attempts to influence use of medications-especially, antipsychotics-in nursing facility care of residents with behavior, mood, and cognitive issues. These improvement efforts can be described as fragmented, often ineffectual, and politically fraught. After decades of effort, and despite a significant reduction in the indiscriminate use of antipsychotics, psychotropics are still widely used in nursing facilities.1 The extent of improvement overall in managing individuals with dementia and other diverse behavior, mood, and cognitive issues is unclear.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抗精神病药物:抗精神病药物:过去、现在和未来(第 2 部分):第 2 条,共 3 条。
护理机构使用抗精神病药物的历史是一个更大、更复杂的谜团中的一个片段。在许多方面,它反映了整个医疗保健系统和提供护理者的优点和局限性。与使用抗精神病药物相关的问题都不是这些药物或护理机构所特有的。经过数十年减少抗精神病药物不当使用的努力,目前的状况仍在不断改进中。许多广为流传的假设和标准说法,如关于行为、药物在以人为本的护理中的地位以及不当用药的原因等,只有部分是正确的。本文是三篇文章中的第二篇,无意讨论如何诊断和管理行为障碍或选择药物。相反,这篇文章将讨论不同的观点、参与其中的关键人物以及他们的努力成果。最终,这将为具体建议(第三部分)奠定基础,即从过去围绕抗精神病药物所做的努力中吸取经验教训,以确定未来更明确、更持久的改进措施。本系列的第 1 部分介绍了护理机构在护理有行为、情绪和认知问题的住院患者时,试图影响药物(尤其是抗精神病药物)使用的历史。这些改进工作可以说是支离破碎,往往效果不佳,而且充满政治色彩。经过数十年的努力,尽管抗精神病药物的滥用已显著减少,但精神药物仍在护理机构中广泛使用。1 在管理痴呆症患者及其他各种行为、情绪和认知问题方面的整体改善程度尚不明确。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Senior Care Pharmacist
Senior Care Pharmacist PHARMACOLOGY & PHARMACY-
CiteScore
1.30
自引率
0.00%
发文量
160
期刊最新文献
Co-designing Medication Optimization Patient-Centered Outcomes Research With Older People and Caregivers as Research Partners. Heart Failure Part 3: Diuretic Management in Older People. How Should the Scope of Pharmacy Practice Be Decided? Marsha Meyer PRESIDENT 2024-2025. Notes on the Consultant Pharmacist Practice Model: At Home and Abroad.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1